Jun 7, 2022 · Harnessing the power of BPO: The active ingredient in EPSOLAY cream is BPO. While it has been used in other products to treat skin conditions like acne, BPO may have …

A new formulation of benzoyl peroxide (E-BPO cream, 5%) entraps benzoyl peroxide (BPO) in silica microcapsules. This study assesses the efficacy, safety, and tolerability of E-BPO cream, …

BPO blocks production of reactive oxygen species. BPO reduces neutrophils that have been implicated in the inflammation of rosacea. BPO is converted into benzoic acid in the skin and …

Jun 15, 2024 · For the first time, sol-gel technology has been successfully introduced into 2 FDA-approved topical drugs, E-BPO/T for acne treatment and E-BPO for rosacea treatment. Sol-gel …

Mar 21, 2023 · Microencapsulated benzoyl peroxide (E-BPO) 5% cream is superior to vehicle in reducing inflammatory lesions in patients with papulopustular rosacea, with E-BPO …

Jul 28, 2023 · Treatment with microencapsulated benzoyl peroxide and tretinoin (E-BPO/T) yielded significant clinical improvement among individuals with moderate to severe acne, …

The efficacy, safety, and tolerability of encapsulated benzoyl peroxide (E-BPO), a topical indicated for the treatment of rosacea, was evaluated in 2 randomized, placebo-controlled, double-blind, …

Objective: We sought to assess the long-term safety and tolerability of microencapsulated benzoyl peroxide cream, 5% (E-BPO cream, 5%), in subjects with rosacea. Efficacy and tolerability …

blind, vehicle-controlled, parallel trials and randomized (2:1) to 12 weeks of once-daily E-BPO/T (n = 571) or vehicle cream (n = 287). Results: E-BPO/T was significantly superior to vehicle in …

Results: E-BPO/T was significantly superior to vehicle in both studies, with more subjects achieving IGA success with E-BPO/T (38.5%/25.4%) versus vehicle (11.5%/14.7%; P < .001/P …